IBD Study Hints at Cause of Postacute COVID

United States News News

IBD Study Hints at Cause of Postacute COVID
United States Latest News,United States Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 55%

A new study among patients with IBD suggests that viral antigen persistence in the gut may contribute to postacute COVID-19 syndrome.

, and 4.3% were unclassified; 23.9% had a history of exposure to antitumor necrosis factor therapy. Among patients in the study, 32 of the patients tested positive for mucosal SARS-CoV-2 RNA, and there was no association between the presence of viral RNA and IBD type.

The researchers found that 52%-70% of patients had antigen persistence in any gut segment, as measured by nucleocapsid immunofluorescence or expression of one of four viral transcripts. They detected persistence of the nucleocapsid in epithelial cells and CD8+ T cells.

The researchers believed that the persistent viral antigen reflects incomplete clearance from the original infection rather than a latent or persistent infection because they could not replicate the virus in biopsy samples. Most biopsies within a patient produced some, but not all, of the viral transcripts tested. The authors suggest that immunosuppressive therapy may lead to incomplete viral clearance.

In fact, only patients with gut antigen persistence had symptoms of postacute COVID."This observation strongly argues for a role of viral antigen persistence in postacute COVID-19 and it appears plausible that SARS-CoV-2 antigen persistence, possibly in infected tissues beyond the gut, could impact host immune responses underlying the postacute COVID-19 syndrome," the researchers wrote.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 symptoms can linger for many weeks, CDC study saysCOVID-19 symptoms can linger for many weeks, CDC study saysThe symptoms could be a headache, a runny nose, a sore throat, as well as loss of smell, taste or hair. Some could even struggle with fatigue, chills or fever.
Read more »

FDA authorizes pharmacists to prescribe Pfizer's pill to treat COVID-19FDA authorizes pharmacists to prescribe Pfizer's pill to treat COVID-19The Food and Drug Administration announced Wednesday that state-licensed pharmacists can now prescribe Paxlovid.
Read more »

As COVID-19 surges, health officials urge people to wear masks againAs COVID-19 surges, health officials urge people to wear masks againAcross the country, more than 100,000 new cases have been reported every day over the past two weeks, but experts say that number could actually be higher.
Read more »

County urges caution as increase in COVID-19 cases, hospitalizations continuesCounty urges caution as increase in COVID-19 cases, hospitalizations continuesAccording to the Health and Human Services Agency, lab-confirmed cases remain near 10,000 per week, not including home tests. The HHSA has seen an increase in people testing positive multiple times. Prior infection doesn't prevent reinfection.
Read more »

COVID-19 cases on the rise: What to know about the state of the pandemicCOVID-19 cases on the rise: What to know about the state of the pandemicEighteen states reported more cases in the week of June 30-July 7 than in the week before, according to a USA TODAY analysis of Johns Hopkins University data.
Read more »

LA County posed to move into 'high' levels of COVID-19 transmissionLA County posed to move into 'high' levels of COVID-19 transmissionLos Angeles County is posed to move into the category of 'high transmission' rates concerning the coronavirus this week.
Read more »



Render Time: 2025-02-23 22:26:42